Journal of Andrology, Vol. 25, No. 4, July/August 2004
Copyright © American Society of Andrology
Cryopreservation of Sperm From Adolescents and Adults With Malignancies
AXEL KAMISCHKE*,
HERBERT JüRGENS
,
LOTHAR HERTLE
,
WOLFGANG E. BERDEL
AND
EBERHARD NIESCHLAG*
From the * Institute of Reproductive Medicine, the
Children's Hospital, the
Urologic Clinic, and the
Department of Medicine/Hematology and Oncology
of the University, D-48129 Münster, Germany.
|
Correspondence to: Dr Eberhard Nieschlag, Institute of Reproductive Medicine
of the University, Domagkstr. 11, D-48129 Münster, Germany (e-mail:
nieschl{at}uni-muenster.de). |
Although cryopreservation of sperm is performed routinely in adults, only a
small amount of information is available on its feasibility in adolescent
patients with malignancies. Of 936 patients who were candidates for sperm
cryopreservation, 851 (111 adolescents and 740 adults) were eligible for this
retrospective analysis after excluding patients with relapses of the original
or secondary cancers, known bitesticular lesions, or an unknown diagnosis. In
general, patients were seen before initiation of treatment for malignancies.
However, unilateral ablation of the testis was performed in 61% of patients
with testicular cancer before cryopreservation of samples. Patients were
grouped according to primary diagnosis and age. Measurements included
testicular volume, semen analysis, and serum hormones (luteinizing hormone
[LH], follicle-stimulating hormone [FSH], and testosterone). The youngest
patient with an ejaculate containing sperm was 13.5 years old. No significant
differences in any investigated parameter could be detected for any diagnosis
among the 111 adolescents (age, <20 years). In contrast, adult patients
with testicular cancer showed higher FSH values and lower sperm concentrations
than adult patients with lymphomas, leukemias, and bone cancers. Patients
younger than 16 years had lower ejaculate volumes than men older than 25
years, and testosterone levels were higher in patients aged 2029 years
than in the youngest patient group. Cryopreservation of sperm can be performed
in adolescent patients with overall success rates (defined as the observation
of at least a single motile sperm after the thawing procedure) similar to
those observed in adults and should be recommended even to oncological
patients younger than 15 years, provided that these patients can produce a
semen sample.
Key words: Cancer, reproduction, fertility, childhood, male
This article has been cited by other articles:

|
 |

|
 |
 
K. E. Orwig and S. Schlatt
Cryopreservation and Transplantation of Spermatogonia and Testicular Tissue for Preservation of Male Fertility
J Natl Cancer Inst Monographs,
March 1, 2005;
2005(34):
51 - 56.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by The American Society of Andrology.